10 Healthcare Stocks with Highest Dividends
In December, CNBC reported that health-care job growth is propping up the labor market at a time when many other industries are struggling.
Merck Sharp & Dohme Corp. (MRK)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (MRK) is currently associated with the following stock: Merck & Co. Inc. (MRK)
Sector: Pharmaceutical Preparations
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.22 | 550 | $18,268.75 | 750 | 2006-01-18 | Filing | |
| $45.65 | 200 | $9,130.56 | 200 | 2002-09-24 | Filing |
News See All
Strong Results Lifted Merck & Co (MRK) in Q4
TCW funds, an investment management company, released its “TCW Relative Value Large Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
15 Best Consistent Dividend Stocks to Buy Right Now
According to an April 6 report by CNBC, if the Iran war drags on longer than expected, investors may want to look at defensive stocks that pay dividends, according to Jefferies.
10 Top Stocks Fund Managers Are Loading Up On in 2026
With the macroeconomic uncertainty looming over the market, the spotlight on institutional positioning gets brighter.
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
Why is Merck & Co. (MRK) One of the Best Affordable Stocks to Buy With Good Earnings Growth?
Merck & Co., Inc. (NYSE:MRK) is one of the best affordable stocks to buy with good earnings growth. Merck & Co., Inc. (NYSE:MRK) and Terns Pharmaceuticals, Inc.
8 Affordable Stocks to Buy With Good Earnings Growth
On March 25, Jim Paulsen, former chief investment strategist at Leuthold Group, appeared on CNBC’s ‘Squawk on the Street’ to talk about the impacts of the Iran war and the stock market.
Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks
In an appearance on CNBC's Fast Money in January, Ray Stevens, CEO of Structure Therapeutics, discussed the unmet potential in the obesity market.
Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion
On March 25, 2026, Merck & Co., Inc. (NYSE:MRK) came into the limelight when Reuters reported that the company had agreed to buy Terns Pharma for $6.7 billion.
Top 10 Stocks to Invest in For Financial Stability
According to the report, geopolitical tensions, particularly the ongoing armed conflict in Iran, are weighing heavily on economists, who believe higher oil prices and broader uncertainty are intensifying...
Hedge Fund Resource Center